Dr. Daniel J. Breault, M.D.
Pulmonology (Pulmonary Disease Physician)
1202 Medical Center Dr, Attn: Credentialing
Wilmington, NC 28401
- Medicare participating
At a glance
- Medical school
- University of Wisconsin School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 427
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: University of Wisconsin School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
NC license 2012-00830 -
Internal Medicine Physician
FL license ME 100992 · IL license 125049041
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Novant Health Presbyterian Medical Center Charlotte, NC
- Novant Health Huntersville Medical Center Huntersville, NC
- Novant Health Mint Hill Medical Center Charlotte, NC
- Novant Health Rowan Medical Center Salisbury, NC
Medical groups
- Novant Health Medical Group, LLC (2,430 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 427
- Services billed
- 1,175
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 209 | 134 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 174 | 72 |
| Established patient office or other outpatient visit, 20-29 minutes | 118 | 95 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 83 | 48 |
| Test to measure rate of airflow | 60 | 59 |
| Critical care, first 30-74 minutes | 52 | 28 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 46 | 45 |
| Test to examine how well the lungs exchange gases | 45 | 45 |
| Test to determine lung volumes using sensors | 45 | 45 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Wilmington, NC | 349 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Wilmington, NC | 240 |
| Prednisone Other prescribers in Wilmington, NC | 145 |
| Azithromycin Other prescribers in Wilmington, NC | 123 |
| Montelukast Sodium Other prescribers in Wilmington, NC | 80 |
| Ipratropium Bromide Other prescribers in Wilmington, NC | 75 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Wilmington, NC | 58 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Wilmington, NC | 54 |
| Azelastine Hcl Other prescribers in Wilmington, NC | 46 |
| Fluticasone Propionate Other prescribers in Wilmington, NC | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 22 payments worth $4,306 in total to this clinician.
| GlaxoSmithKline, LLC. | $4,083 |
|---|---|
| Insmed, Inc. | $110 |
| Genzyme Corporation | $62.20 |
| Regeneron Healthcare Solutions, Inc. | $32.13 |
| Philips North America LLC | $19.34 |
| Compensation for services other than consulting (speaking, faculty) | $3,900 |
|---|---|
| Food and Beverage | $389 |
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. Jan 23, 2025 | Compensation for services other than consulting (speaking, faculty) AREXVY · RESPIRATORY | $3,900 |
| Insmed, Inc. Sep 22, 2025 | Education in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.